CRN Support For NAD At 10 Years: 250 Ad Claim Reviews, Better Industry Image
This article was originally published in The Tan Sheet
Executive Summary
"We hoped that it would have legs and it would last," says CRN President and CEO Steve Mister. "We thought, 'If it makes a difference, if we feel like we actually are doing something of value for the industry, we'll keep it up'."
You may also be interested in...
CRN Ends Funding For Industry Self-Regulation Program Focused On Supplement Advertising
The trade group ends funding for National Advertising Division program launched in 2006 for increased focus on monitoring supplement claims, reviewing 360 in total. Separately, NAD launches an expedited challenge process aiming to conclude reviews in 20 business days.
'Enhanced Brain Function' Supplement Sales Only A Memory After NAD Review
Council of Better Business Bureau's industry self-regulation arm says UltraMax Health, after previously not responding to a request for evidence supporting Max Synapse online ad claims, stated in writing that it stopped using the claims and no longer is selling the product.
Opiate Addiction Remedy Claims Could Face FTC Substantiation Test
The Council of Better Business Bureaus' investigative arm asks Opiate Freedom Center for evidence to substantiate ad claims including "Home Remedies for Opiate Withdrawal Symptom Relief" and supplements "developed to naturally replenish depleted nutrients during opiate detox and withdrawal."